SWOG clinical trial number
CTSU/A011502

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial

Open
Phase
Abbreviated Title
The ABC Trial: Rando PIII Double Blind Placebo/Aspirin for Node+ / HER2- Breast Cancer
Status Notes
This study is active in SWOG effective 4/15/17.
Activated
04/15/2017
Participants
CTSU

Research committees

Breast Cancer

Treatment

Aspirin

Other Clinical Trials

S2206
SWOG Clinical Trial Number

A Randomized trial of neoadjuvant durvalumab plus chemotherapy versus chemotherapy alone for Adults with MammaPrint Ultrahigh (MP2) hormone receptor (HR) positive /Human Epidermal Growth Factor receptor (HER2) negative stage II-III breast cancer

Research Committee(s)
Breast Cancer
Symptom Control and Quality of Life
Activated
10/30/2023
17% Accrual
Accrual
17%
Open
Phase
S2212
SWOG Clinical Trial Number

TIL Adapted Neo adjuvant Chemotherapy Optimization in Triple negative breast cancer (SCARLET)

Research Committee(s)
Breast Cancer
Activated
07/21/2023
25% Accrual
Accrual
25%
Open
Phase
CTSU/NRG-BR007
SWOG Clinical Trial Number

A Phase III Clinical Trial Evaluating De-escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score </= 18 Breast Cancer

Research Committee(s)
Breast Cancer
Activated
06/07/2021
Open
Phase